AstraZeneca
exciting pipeline progress in rapidly advancing high potential new medicines blockbuster medicines with durable profile positive phase read outs across unique medicines initiating phase trials in adjuvant her breast cancer regulatory approvals in major markets phase and projects or major several phase including hypertension | AstraZeneca
Company
Deck Type
Deck date
February 2023
Slide
6 of 45
Related slides by other companies
SPAC
October 2021
Investor Presentation
February 2023
Investor Presentation
January 2024
Investor Presentation
January 2024
Other recent decks by AstraZeneca
Results
February 2024
Investor Conference
January 2024
Results
November 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io